Federal RuleAug 21
62
DOL Rewrites Disability Rules for 'Merit-Based Opportunity' Push
RuleLabor DepartmentFederal Contract Compliance Programs OfficeSignificant Wallet
116-hr-4866116th Congress
National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2020
Sponsored By: Representative Pallone, Frank [D-NJ-6]
Unknown
Summary
National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2019 This bill directs the Food and Drug Administration (FDA) to designate qualified institutions of higher education as National Centers of Excellence in Continuous Pharmaceutical Manufacturing and to provide grants to the centers. Each designated center must conduct research on continuous manufacturing technologies and must share information from such research with the FDA. (Currently, most drug production involves batch manufacturing, which typically takes longer than continuous manufacturing processes.)
Personalized for You
How does this bill affect your finances?
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Bill Overview
No Economic Impacts Identified for this Bill
Sponsors & CoSponsors
Sponsor
Pallone, Frank [D-NJ-6]
NJ • D
Cosponsors
Rep. Guthrie, Brett [R-KY-2]
KY • R
Sponsored 10/28/2019
Rep. Spanberger, Abigail Davis [D-VA-7]
VA • D
Sponsored 5/12/2020
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov